Valneva SE
INRLF News Today: Stay Updated with the Latest Valneva SE News in Real Time
Find INRLF news now at Meyka AI. Stay informed with the latest Valneva SE stocks updates, including price news, market analysis, and expert insights.
VLA.PA Stock Today: April 6 – Selloff Deepens on Lyme Data, PT Cuts
Valneva stock slides as Lyme vaccine data miss fuels price target cuts and regulatory uncertainty. Swiss investors watch €2.80–3.00 support, RSI oversold, and May 7 earnings for clues.
VLA.PA stock down 39.01% to €2.78 pre-market: Pfizer trial shifts valuation outlook
Pre-market: VLA.PA stock falls 39.01% to €2.78 on heavy volume; analysis, valuation and forecast
VLA.PA Valneva EURONEXT up 0.98% intraday ahead of Q4 16 Mar 2026: earnings to watch
Intraday earnings spotlight on VLA.PA stock: Valneva SE reports Q4 on 18 Mar 2026. We analyse metrics, risks and Meyka AI forecast of EUR 5.30.
Valneva SE (VLA.PA EURONEXT) after hours: Q4 earnings preview 13 Mar 2026
VLA.PA stock trades at €4.53 after hours on 13 Mar 2026 ahead of Q4 results and guidance; Meyka AI outlook and forecast included.
€4.93 pre-market VLA.PA Valneva SE EURONEXT 11 Mar 2026 earnings: catalysts
VLA.PA stock pre-market at €4.93 ahead of 11 Mar 2026 earnings; read catalysts and Meyka AI forecast for upside/downside.
Price up 6.49% to €4.63: VLA.PA Valneva SE EURONEXT 18 Feb 2026, watch earnings
VLA.PA stock rose 6.49% to €4.63 on EURONEXT; Meyka forecast shows +8.89% yearly upside for VLA.PA stock
DVAX Stock Today: Sanofi’s $2.2B Buyout Sharpens Vaccine Push — December 26
Sanofi Dynavax deal lifts DVAX focus as Sanofi moves to buy Dynavax for $2.2B. We break down terms, stock reaction, approvals, and what US investors should watch next.